open access
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study
- Kliniczny Oddział Neurologii, Samodzielny Publiczny Szpital Kliniczny nr 1, Śląski Uniwersytet Medyczny w Katowicach
- Katedra i Klinika Neurologii Collegium Medicum, Uniwersytet Jagielloński w Krakowie
open access
Abstract
The aim of this study was to evaluate the concentration of 25(OH)D3 and the indices of calcium and phosphorus metabolism at different times of relapsing-remitting multiple sclerosis (MS). The relationships between the concentrations of 25(OH)D3 and the indices of calcium-phosphate metabolism were determined, depending on the duration of disease and vitamin and unsaturated fatty acids supplementation.
Material and methodsThirty patients (15 at the early stage and 15 at the advanced stage of MS) were enrolled. Each patient underwent neurological examination; neurological motor disability was defined according to the Expanded Disability Status Scale (EDSS). The results were compared to the values obtained in the control group (15 individuals) selected according to the age of subjects, their residence, ethnicity and gender.
ResultsSignificantly lower serum concentrations of 25(OH)D3 in MS patients compared to the control group were found. MS patients at the advanced stage of the disease (duration of 5–6 years) had lower 25(OH)D3 concentrations than patients at the early stage of MS. Among patients in an advanced stage of MS, significantly lower levels of 25(OH)D3 were found in women compared to men with a similar level of physical disability.
ConclusionsLower serum concentrations of 25(OH)D3 in MS patients compared to the control group were found. The lowest concentrations of 25(OH)D3 were found in female patients aged 20–40 and in patients with a longer disease duration without substantial impairment of calcium-phosphate metabolism.
Abstract
The aim of this study was to evaluate the concentration of 25(OH)D3 and the indices of calcium and phosphorus metabolism at different times of relapsing-remitting multiple sclerosis (MS). The relationships between the concentrations of 25(OH)D3 and the indices of calcium-phosphate metabolism were determined, depending on the duration of disease and vitamin and unsaturated fatty acids supplementation.
Material and methodsThirty patients (15 at the early stage and 15 at the advanced stage of MS) were enrolled. Each patient underwent neurological examination; neurological motor disability was defined according to the Expanded Disability Status Scale (EDSS). The results were compared to the values obtained in the control group (15 individuals) selected according to the age of subjects, their residence, ethnicity and gender.
ResultsSignificantly lower serum concentrations of 25(OH)D3 in MS patients compared to the control group were found. MS patients at the advanced stage of the disease (duration of 5–6 years) had lower 25(OH)D3 concentrations than patients at the early stage of MS. Among patients in an advanced stage of MS, significantly lower levels of 25(OH)D3 were found in women compared to men with a similar level of physical disability.
ConclusionsLower serum concentrations of 25(OH)D3 in MS patients compared to the control group were found. The lowest concentrations of 25(OH)D3 were found in female patients aged 20–40 and in patients with a longer disease duration without substantial impairment of calcium-phosphate metabolism.
Keywords
multiple sclerosis, 25(OH)D3, dietary supplements
Title
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study
Journal
Neurologia i Neurochirurgia Polska
Issue
Pages
126-130
Page views
237
Article views/downloads
298
DOI
10.5114/ninp.2013.34730
Bibliographic record
Neurol Neurochir Pol 2013;47(2):126-130.
Keywords
multiple sclerosis
25(OH)D3
dietary supplements
Authors
Katarzyna Kubicka
Krystyna Pierzchała